Vertex to Participate in Upcoming Investor Conferences
November 09 2022 - 8:00AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced its participation in the following upcoming investor
conferences:
- Jefferies London Healthcare Conference on Wednesday, November
16, 2022, at 9:10 a.m. GMT (4:10 a.m. EST)
- 5th Annual Evercore ISI HealthCONx Conference on Wednesday,
November 30, 2022, at 9:15 a.m. EST
A live webcast of management’s remarks will be available through
Vertex’s website, www.vrtx.com in the “Investors” section under the
“News and Events” page. A replay of the conference webcasts will be
archived on the company’s website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has multiple approved medicines
that treat the underlying cause of cystic fibrosis (CF) — a rare,
life-threatening genetic disease — and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational small molecule, cell and genetic
therapies in other serious diseases where it has deep insight into
causal human biology, including sickle cell disease, beta
thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes,
alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London. Additionally, the company
has research and development sites and commercial offices in North
America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 13 consecutive years on Science magazine's Top
Employers list and one of Fortune’s Best Workplaces in
Biotechnology and Pharmaceuticals and Best Workplaces for Women.
For company updates and to learn more about Vertex's history of
innovation, visit www.vrtx.com or follow us on Facebook, Twitter,
LinkedIn, YouTube and Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221109005068/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
Susie Lisa, 617-341-6108 Manisha Pai, 617-961-1899 Miroslava
Minkova, 617-341-6135
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Oct 2023 to Oct 2024